De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Top Cited Papers
Open Access
- 10 January 2018
- journal article
- research article
- Published by Wiley in Molecular Informatics
- Vol. 37 (1-2)
- https://doi.org/10.1002/minf.201700153
Abstract
Generative artificial intelligence offers a fresh view on molecular design. We present the first-time prospective application of a deep learning model for designing new druglike compounds with desired activities. For this purpose, we trained a recurrent neural network to capture the constitution of a large set of known bioactive compounds represented as SMILES strings. By transfer learning, this general model was fine-tuned on recognizing retinoid X and peroxisome proliferator-activated receptor agonists. We synthesized five top-ranking compounds designed by the generative model. Four of the compounds revealed nanomolar to low-micromolar receptor modulatory activity in cell-based assays. Apparently, the computational model intrinsically captured relevant chemical and biological knowledge without the need for explicit rules. The results of this study advocate generative artificial intelligence for prospective de novo molecular design, and demonstrate the potential of these methods for future medicinal chemistry.Keywords
This publication has 20 references indexed in Scilit:
- Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensusProceedings of the National Academy of Sciences of the United States of America, 2014
- The ChEMBL bioactivity database: an updateNucleic Acids Research, 2013
- De Novo Drug DesignPublished by Springer Science and Business Media LLC ,2010
- International Union of Pharmacology. LXIII. Retinoid X ReceptorsPharmacological Reviews, 2006
- International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated ReceptorsPharmacological Reviews, 2006
- Computer-based de novo design of drug-like moleculesNature Reviews Drug Discovery, 2005
- Identification of a subtype selective human PPARα agonist through parallel-array synthesisBioorganic & Medicinal Chemistry Letters, 2001
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Long Short-Term MemoryNeural Computation, 1997
- Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective RetinoidsJournal of Medicinal Chemistry, 1994